Bromine, bear-claw scratch fasciotomies, and the Eagle effect: management of group A streptococcal necrotising fasciitis and its association with trauma

被引:13
作者
Lamb, Lucy E. M. [1 ]
Sriskandan, Shiranee [1 ]
Tan, Lionel K. K. [1 ]
机构
[1] Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, Dept Med, London W12 0NN, England
基金
英国惠康基金;
关键词
TOXIC-SHOCK-SYNDROME; INTRAVENOUS IMMUNOGLOBULIN THERAPY; HYPERBARIC-OXYGEN THERAPY; M-PROTEIN; CYSTEINE PROTEINASE; VIMENTIN EXPRESSION; HOSPITAL GANGRENE; PYOGENES DISEASE; MUSCLE INJURY; RISK-FACTORS;
D O I
10.1016/S1473-3099(14)70922-3
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Necrotising fasciitis is a rare, but potentially fatal, soft-tissue infection. Historical depictions of the disease have been described since classical times and were mainly recorded in wartime reports of battle injuries. Although several different species of bacteria can cause necrotising fasciitis, perhaps the most widely known is group A streptococcus (GAS). Infection control, early surgical debridement, and antibiotic therapy are now the central tenets of the clinical management of necrotising fasciitis; these treatment approaches all originate from those used in wars in the past 150 years. We review reports from the 19th century, early 20th century, and mid-20th century onwards to show how the management of necrotising fasciitis has progressed in parallel with prevailing scientific thought and medical practice. Historically, necrotising fasciitis has often, but not exclusively, been associated with penetrating trauma. However, along with a worldwide increase in invasive GAS disease, recent reports have cited cases of necrotising fasciitis following non-combat-related injuries or in the absence of antecedent events. We also investigate the specific association between GAS necrotising fasciitis and trauma. In the 21st century, molecular biology has improved our understanding of GAS pathogenesis, but has not yet affected attributable mortality.
引用
收藏
页码:109 / 121
页数:13
相关论文
共 160 条
[1]  
Abraham EP, 1941, LANCET, V2, P177
[2]   STREPTOCOCCAL MYOSITIS [J].
ADAMS, EM ;
GUDMUNDSSON, S ;
YOCUM, DE ;
HASELBY, RC ;
CRAIG, WA ;
SUNDSTROM, WR .
ARCHIVES OF INTERNAL MEDICINE, 1985, 145 (06) :1020-1023
[3]   Protein SIC, a novel extracellular protein of Streptococcus pyogenes interfering with complement function [J].
Akesson, P ;
Sjoholm, AG ;
Bjorck, L .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (02) :1081-1088
[4]   THE CONTRIBUTIONS OF INFECTION CONTROL TO A CENTURY OF SURGICAL PROGRESS [J].
ALEXANDER, JW .
ANNALS OF SURGERY, 1985, 201 (04) :423-428
[5]   Group A streptococcal infections in primary care: a case report [J].
Baker, Adrian .
BRITISH JOURNAL OF GENERAL PRACTICE, 2012, 62 (600) :388-389
[6]  
Barnes J., 1870, MED SURG HIST CIVIL
[7]   Genome sequence of a serotype M3 strain of group A Streptococcus:: Phage-encoded toxins, the high-virulence phenotype, and clone emergence [J].
Beres, SB ;
Sylva, GL ;
Barbian, KD ;
Lei, BF ;
Hoff, JS ;
Mammarella, ND ;
Liu, MY ;
Smoot, JC ;
Porcella, SF ;
Parkins, LD ;
Campbell, DS ;
Smith, TM ;
McCormick, JK ;
Leung, DYM ;
Schlievert, PM ;
Musser, JM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (15) :10078-10083
[8]  
Bernal NP, 2012, BURNS
[9]  
Billroth T, 1894, MUTUAL ACTION LIVING
[10]   Causative Pathogens, Antibiotic Sensitivity, Resistance Patterns, and Severity in a Contemporary Series of Fournier's Gangrene [J].
Bjurlin, Marc A. ;
O'Grady, Thomas ;
Kim, Dae Y. ;
Divakaruni, Naveen ;
Drago, Andrew ;
Blumetti, Jennifer ;
Hollowell, Courtney M. P. .
UROLOGY, 2013, 81 (04) :752-758